Albert Bourla - 29 May 2026 Form 4 Insider Report for PFIZER INC (PFE)

Reporting relationship: Chairman & CEO, Director
Issuer ticker: PFE
Reported as of: 29 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 01 Jun 2026, 19:42:34 UTC
Prior SEC filing: 18 May 2026
Next SEC filing: 16 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Esther H. Louis, by power of attorney, for Albert Bourla

Key filing fact

Albert Bourla filed Form 4 for PFIZER INC (PFE) on 01 Jun 2026.

Key facts

This page summarizes Albert Bourla's Form 4 filing for PFIZER INC (PFE).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 01 Jun 2026, 19:42.

Change

Previous filing in this sequence was filed on 18 May 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001595703 Primary reporting owner

BOURLA ALBERT

Relationship: Chairman & CEO, Director
Address: 66 HUDSON BOULEVARD EAST, ATTN: CORPORATE SECRETARY, NEW YORK
Signature: /s/ Esther H. Louis, by power of attorney, for Albert Bourla
Signature date: 01 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PFE transaction Derivative

Phantom Stock Units SSP

Award

Transaction value
Shares: +23
Change %: +0%
Price: $26.18^*
Shares after: 772,789
Date: 29 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 23
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each unit represents one phantom share of common stock.

Footnote F2

These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.